The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects
Open accessAbstract
Background and aims Abdominal fat accumulation (visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG).Methods In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 +/- 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-(3)H-glucose) and GNG ((2)H(2)O) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (LF) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging.Results LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% +/- 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 micromol/min/kg(ffm); P = .02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 micromol/min/kg(ffm); P = .02). Basal hepatic IR index (EGP x fasting plasma insulin) was increased in T2DM (NGT, 816 +/- 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P = .007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05).Conclusions Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Except for a recent study of Gastaldelli et al, 17 who found no difference in insulin clearance between lean normal subjects and lean or obese type 2 diabetic patients, there are no studies in which carefully matched groups of type 2 diabetic patients and nondiabetic subjects would have been compared with respect to liver fat, hepatic insulin sensitivity, and insulin clearance.”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
In the citing paper
“In small groups of diabetic patients, insulin clearance has reported to be normal, 16 -18 decreased, 19,20 or even increased.21”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Research works printed but not linked: 1
- Matsuda, 1997, Relationship between insulin sensitivity in adipose tissue, liver, muscle and components of the insulin resistance syndrome, Diabetes, 46, 68A
Cited by
Sorted by citations
Items 401–500 of 629
de Toro‐Martín, J., Guénard, F., Tchernof, A., Deshaies, Y., Përusse, L., Hould, F., Lebel, S., Marceau, P., & Vohl, M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0171-3 · Cited by 13
Tricò, D., Galderisi, A., Name, M. A. V., Caprio, S., Samuels, S. L., Li, Z., Galuppo, B., Savoye, M., Mari, A., Feldstein, A. E., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14695 · Cited by 11
Xu, Y., Liu, Y.-H., Zhou, X., Wang, Y., Deng, J., Liu, J., He, H., & Xu, Z. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.02.052 · Cited by 12
Spadaccini, D., Perna, S., Peroni, G., D’Antona, G., Iannello, G., Faragli, A., Infantino, V., Riva, A., Petrangolini, G., Negro, M., et al. (2020) · Life · doi:10.3390/life10090163 · Cited by 13
Impact of rural-urban environment on metabolic profile and response to a 5-day high-fat diet
Tahapary, D. L., de Ruiter, K., Kurniawan, F., Djuardi, Y., Wang, Y., Nurdin, S. M. E., Iskandar, E., Minggu, D., Yunir, E., Guigas, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25092-6 · Cited by 12
Talamonti, E., Davegardh, J., Kalinovich, A., van Beek, S. M. M., Dehvari, N., Halleskog, C., Bokhari, M. H., Hutchinson, D. S., Ham, S., Humphrys, L. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101931 · Cited by 10
Alotaibi, T. F., Thackray, A. E., Roberts, M. J., Alanazi, T. M., BISHOP, N. C., Wadley, A. J., King, J. A., O’Donnell, E., STEINER, M. C., Singh, S. J., et al. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002560 · Cited by 11
Obesity risk is associated with brain glucose uptake and insulin resistance
Pekkarinen, L., Kantonen, T., Rebelos, E., Latva‐Rasku, A., Dadson, P., Karjalainen, T., Bucci, M., Kalliokoski, K. K., Laitinen, K., Houttu, N., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0509 · Cited by 12
Neidert, L. E., Wainright, K. S., Zheng, C., Babu, J. R., & Kluess, H. A. (2016) · Heliyon · doi:10.1016/j.heliyon.2016.e00097 · Cited by 11
Morrison, D., Kowalski, G. M., Bruce, C. R., & Wadley, G. D. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00500.2018 · Cited by 11
Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop
Peters, H. P. F., Schrauwen, P., Verhoef, P., Byrne, C. D., Mela, D. J., Pfeiffer, A. F. H., Risérus, U., Rosendaal, F. R., & Schrauwen‐Hinderling, V. B. (2017) · Journal of Nutritional Science · doi:10.1017/jns.2017.13 · Cited by 11
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_8-1 · Cited by 11
Malaikah, S., Willis, S. A., Henson, J. J., Sargeant, J. A., Yates, T. E., Thackray, A. E., Goltz, F. R., Roberts, M. J., Bodicoat, D. H., Aithal, G. P., et al. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01350-0 · Cited by 11
He, J., Zhang, B., Fan, Y., Wang, Y., Zhang, M., Li, C., Zhang, L., Guo, P., & Zhang, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1001397 · Cited by 10
The color of fat and its central role in the development and progression of metabolic diseases
Gaggini, M., Carli, F., & Gastaldelli, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0060 · Cited by 11
Calixto-Tlacomulco, S., Luna-Reyes, I., Delgado‐Coello, B., Gutiérrez‐Vidal, R., Reyes‐Grajeda, J. P., & Mas‐Oliva, J. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102937 · Cited by 9
Willis, S. A., Malaikah, S., Bawden, S. J., Sherry, A. P., Sargeant, J. A., Coull, N. A., Bradley, C. R., Rowlands, A., Naim, I., Ennequin, G., et al. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15755 · Cited by 9
Choi, Y. J., Park, J.-H., Cho, H.-I., Shin, M., & Nah, E. (2025) · Metabolites · doi:10.3390/metabo15050299 · Cited by 10
Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
Gastaldelli, A., Scoditti, E., & Macedo, M. P. (2026) · Diabetologia · doi:10.1007/s00125-026-06774-7 · Cited by 11
Current approaches to diagnosing and treating nonalcoholic fatty liver disease
Никонов, Е. Л., & Va, A. (2018) · Russian Journal of Preventive Medicine · doi:10.17116/profmed201831262 · Cited by 9
Nonalcoholic Fatty Liver Disease
Dancygier, H. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_35 · Cited by 11
Wang, B., Li, F., Guo, J., Wang, C., Xu, D., & Li, C. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7043 · Cited by 9
Defining and characterising the progression of type 2 diabetes
Fonseca, V. A. (2008) · The British Journal of Diabetes · doi:10.1177/1474651408100520 · Cited by 9
Guo, W., Xue, H., Li, Q., Wen, Z., Zhou, Z., Dong, Y., He, M., Li, Y., Li, F., & Tong, Y. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.03.010 · Cited by 8
Pompili, S., Cappariello, A., Vetuschi, A., & Sferra, R. (2024) · ACS Omega · doi:10.1021/acsomega.4c03507 · Cited by 8
Mechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
Alfawaz, S. A., Burzangi, A. S., & Esmat, A. (2024) · Cureus · doi:10.7759/cureus.67080 · Cited by 9
Han, T., Li, Y., Xiao, J., Gong, H., Deng, F., Jiang, W., Wang, C., Chen, F., Zhang, C., Deng, J., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s469398 · Cited by 8
Nyakudya, T. T., Makaula, S., Mkumla, N., & Erlwanger, K. H. (2014) · International Journal of Agriculture and Biology · Cited by 8
Nakajima, T., Nakashima, T., Yamaoka, J., Shibuya, A., Itoh, Y., & Yoshikawa, T. (2012) · Journal of Gastroenterology and Hepatology Research · Cited by 8
Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease
Iruzubieta, P., González, M., Cabezas, J., Arias-Loste, M. T., & Crespo, J. (2018) · InTech eBooks · doi:10.5772/intechopen.72668 · Cited by 8
Guan, Y., Xu, Y., Su, H. W., Sun, X., Li, Y., & Wang, T. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2039284 · Cited by 8
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Ramalho, F. N. Z., Sanches, S. C., Foss, M. C., Augusto, M. J., Silva, D. M., de Oliveira, A. M., & Ramalho, L. N. Z. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0282-5 · Cited by 8
Pan, Y., Rong, Y., Huang, J., Zhu, K., Chen, J., Yu, C., & Chen, M. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.014 · Cited by 9
Rodriguez, N. S., & Hartmann, P. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100058 · Cited by 10
Lee, J., Jeon, S., Lee, H. S., & Kwon, Y. (2023) · Nutrients · doi:10.3390/nu15132880 · Cited by 8
Insulin Dynamics and Pathophysiology in Youth-Onset Type 2 Diabetes
Abu-Nejem, R., & Hannon, T. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae463 · Cited by 7
Rafsanjani, K., Rabizadeh, S., Ebrahimiantabrizi, A., Asadibideshki, Z., Yadegar, A., Esteghamati, A., Nakhjavani, M., & Reyhan, S. K. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04297-w · Cited by 10
Mostazir, M., Jeffery, A., Voss, L. D., & Wilkin, T. J. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00157.x · Cited by 7
Obesity as an Early Symptom of the AMIS Syndrome
Lautt, W. W., & Wang, H. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041178 · Cited by 7
Nagoya, T., Kamimura, K., Goto, R., Shinagawa‐Kobayashi, Y., Niwa, Y., Kimura, A., Sakai, N., Ko, M., Nishina, H., & Terai, S. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12734 · Cited by 7
Szotkowská, R., Gojda, J., Plíhalová, A., Weichet, J., Potočková, J., Havlík, J., Polak, J., & Anděl, M. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000519251 · Cited by 7
Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
Oe, N., Takeda, H., Eso, Y., Takai, A., & Marusawa, H. (2022) · Pathogens · doi:10.3390/pathogens11040430 · Cited by 7
Macías‐Rodríguez, R. U., & Torre, A. (2009) · Revista de investigaci�n Cl�nica · Cited by 7
Fatty liver and renal function impairment – Time for awareness?
Pais, R., & Bourron, O. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.016 · Cited by 7
Smith, K., Taylor, G., Peeters, W., Walker, M., Perazzolo, S., Atabaki‐Pasdar, N., Davies, K. A. B., Karpe, F., Hodson, L., Stevenson, E., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06249-7 · Cited by 6
Wu, Z., Liang, G., Zhang, Y., & Li, R. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.01.011 · Cited by 6
Lyu, Y. S., Park, M., Kim, H. K., Park, S., Park, J. Y., Hong, A. R., Yoon, J. H., Jeong, S., Yoon, Y., Kim, J. H., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02793-7 · Cited by 6
Function of PNPLA3 I148M —Lessons From In Vivo Studies in Humans
Yki‐Järvinen, H., & Luukkonen, P. K. (2025) · Liver International · doi:10.1111/liv.70047 · Cited by 7
Chowdhury, K. K., Légaré, D. J., & Lautt, W. W. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0228 · Cited by 7
Non-Alcoholic Fatty Steatohepatitis an Inflammatory Disorder Beyond the Liver
Cerpa‐Cruz, S. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000159 · Cited by 6
Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural
Ortíz, J. E. P., Luque, C. B. S., & Quiróz, R. J. O. (2022) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.952 · Cited by 9
Pathogenesis of nonalcoholic fatty liver disease (NAFLD)
Yki‐Järvinen, H. (2015) · doi:10.1002/9781118387658.ch19 · Cited by 6
Cao, Y., Xu, R., & Zhang, J. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1679527 · Cited by 5
Associations between metabolic phenotypes and diabetes risk: A systematic review and meta-analysis
Vera-Ponce, V. J., Loayza-Castro, J. A., Zuzunaga-Montoya, F. E., Torres-Malca, J. R., García-Lara, R. A., Paucar, C. R. I., Orihuela-Manrique, E. J., Valladares-Garrido, M. J., & Cruz-Vargas, J. A. D. L. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100142 · Cited by 5
Gastric Submucosal Fat Accumulation Is Associated with Insulin Resistance in Patients with Obesity
Lu, T., Kan, J., He, X., Zou, J., Sheng, D., Xue, Y., Wang, Y., & Xu, L. (2024) · Obesity Surgery · doi:10.1007/s11695-023-07014-2 · Cited by 5
Wang, C., Batey, R. G., Yamahara, J., & Li, Y. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.06.040 · Cited by 5
Dislipidemias, hígado graso y enfermedad cardiovascular
Hidalgo, I., Fonseca-Coronado, S., Ceballos, G. M., Meaney, E., & Nájera, N. (2022) · Cardiovascular and Metabolic Science · doi:10.35366/107628 · Cited by 5
Czegle, I., Margittai, É., Senesi, S., Benedetti, A., & Bánhegyi, G. (2008) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.95.2008.4.8 · Cited by 5
Fujibayashi, K., Gunji, T., Yokokawa, H., Naito, T., Sasabe, N., Okumura, M., Iijima, K., Shibuya, K., Hisaoka, T., & Fukuda, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149689 · Cited by 5
Pozuelo-Sanchez, I., Villasanta‐Gonzalez, A., Alcala-Diaz, J. F., Vals‐Delgado, C., Leon‐Acuña, A., Gonzalez-Requero, A., Yubero‐Serrano, E. M., Luque, R. M., Caballero‐Villarraso, J., Quesada, I., et al. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06801 · Cited by 5
Huang, W., Xie, C., Albrechtsen, N. J. W., Sang, M., Sun, Z., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2023) · Peptides · doi:10.1016/j.peptides.2023.171092 · Cited by 5
Tan, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00036-2 · Cited by 5
Wang, B., Shao, Y., & Liang, R. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin44389 · Cited by 5
MASLD and the cardiovascular-kidney-liver-metabolic syndrome
Angelidi, A. M., Boutari, C., Kokkorakis, M., Stefanakis, K., Mikhailidis, D. P., Jacob, G., & Mantzoros, C. S. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnag023 · Cited by 6
Resting and exercise metabolic characteristics in obese children with insulin resistance
Cao, Y., Lin, Z., Chen, Z., & Xie, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1049560 · Cited by 4
Lattuada, G., Radaelli, M. G., COBELLI, F. D., Esposito, A., Manzoni, G., Perra, S., Maschio, A. D., Castoldi, G., & Perseghin, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9796175 · Cited by 4
Lee, M. H., Febriana, E., Lim, M., Baig, S., Halter, J. B., Magkos, F., & Toh, S.-A. E. S. (2023) · Obesity · doi:10.1002/oby.23833 · Cited by 4
Baskoy, G., Peterson, R. M., Kempenich, J. W., Triplitt, C. L., Brown, M., Clarke, G. D., Cersósimo, E., Mark, A., Lavrynenko, O., Chavez-Velazquez, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae872 · Cited by 4
Hurjui, D. M., Niță, O., Graur, L. I., Popescu, D. Ş., Mihalache, L., Huţanaşu, C., & Graur, M. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0037-x · Cited by 4
Klein, S., Fabbrini, E., & Romijn, J. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00036-5 · Cited by 4
NAFLD and Insulin Resistance: A Multisystemic Disease
Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4
The Role of Ethylcellulose Oleogel in Human Health and Its Potential Applications
Tan, S., Peh, E. W. Y., Siow, P. C., & Henry, C. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814270-7.00017-4 · Cited by 4
Ortaglia, A., McDonald, S. M., Supino, C., Wirth, M. D., Sui, X., & Bottai, M. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2020.101083 · Cited by 5
Dapagliflozin combination therapy in type 2 diabetes mellitus
Yacoub, T. G. (2015) · Postgraduate Medicine · doi:10.1080/00325481.2016.1111119 · Cited by 4
Nyamdorj, R. (2010) · Työväentutkimus Vuosikirja · Cited by 4
Doncheva, A. I., Higa, R., Khanal, P., Ingebrigtsen, M., Li, Y., Kolan, S. S., Kolan, P., Kvasnička, A., Jermstad, I., Khan, S., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111043 · Cited by 3
Diagnosis and Management of Horses with Equine Metabolic Syndrome (EMS)
Chameroy, K. A. (2010) · Cited by 3
Insulin and the Physiology of Carbohydrate Metabolism
Pereira, S., & Giacca, A. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_1 · Cited by 3
Wang, Y., Zhang, X., Zhong, M., Liu, T., Zhang, G., Liu, S., Guo, W., Meng, W., He, Q., Sun, D., et al. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1997-8 · Cited by 3
Owolabi, L., Adebisi, S., Danborno, B., & Buraimoh, A. (2016) · Nigerian Journal of Basic and Clinical Sciences. · doi:10.4103/0331-8540.176044 · Cited by 3
Hernández‐Rodas, M. C., Jessica Morales, P., Rodrigo Valenzuela, B., Morales, G. I., & Alfonso Valenzuela, B. (2016) · Revista chilena de nutrición · doi:10.4067/s0717-75182016000200013 · Cited by 5
Quantitative Proteomic Analysis of Hepatic Tissue of T2DM Rhesus Macaque
Du, T., Lu, S.-Y., Jiang, Q., Li, Y., & Ma, K. (2017) · Journal of Diabetes Research · doi:10.1155/2017/3601708 · Cited by 4
Granda, M. L., Amarapurkar, P. D., & Fornoni, A. (2018) · Clinical Science · doi:10.1042/cs20171490 · Cited by 3
Body composition of type 2 diabetes patients in Uganda: A case-control study
Buyinza, R., Nsamba, J., Muyingo, A., Matovu, N., Nabirye, G., Kantengwa, A., Akandunda, S., Sseguya, W., & Mathews, E. (2023) · Journal of Public Health in Africa · doi:10.4081/jphia.2023.2249 · Cited by 3
Martín, I. S. M., Vilar, E. G., Rojo, S. S., Oliva, S. L., Martínez, S., & Lora, A. T. (2023) · Nutrición Hospitalaria · doi:10.20960/nh.04635 · Cited by 3
Reed, R. M., Shojaee‐Moradie, F., Whelehan, G., Jackson, N., Witard, O. C., Umpleby, A. M., Fielding, B. A., Whyte, M., & Goff, L. M. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00164.2024 · Cited by 3
Westcott, F., Nagarajan, S. R., Parry, S. A., Savic, D., Green, C., Marjot, T., Johnson, E. M., Cornfield, T., Mózes, F. E., O’Rourke, P., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae123 · Cited by 6
Quantification of Insulin Action in Human Subjects
Krentz, A. J., Weyer, C., & Hompesch, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_1 · Cited by 3
Tremblay‐Franco, M., Poupin, N., Amiel, A., Canlet, C., Rémond, D., Debrauwer, L., Dardevet, D. P., Jourdan, F., Savary‐Auzeloux, I., & Polakof, S. (2020) · Nutrients · doi:10.3390/nu12082442 · Cited by 3
Recent progress in analysis of intermediary metabolism by ex vivo 13C NMR
Malloy, C. R., Sherry, A. D., Alger, J. R., & Jin, E. S. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4817 · Cited by 3
Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD)
Aithal, G. P., Das, K., & Chowdhury, A. (2014) · Wiley eBooks · doi:10.1002/9781118727072.ch32 · Cited by 3
Utility of magnetic resonance imaging in the evaluation of hepatic fat content #
Manco, M., & Nobili, V. (2009) · Hepatology · doi:10.1002/hep.23039 · Cited by 3
Correction: Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk
Tran, M., Gallo, L. A., Wadley, G. D., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2012) · PLoS ONE · doi:10.1371/annotation/0a0f4d8b-8ec3-4d62-8d0b-1917716beaa0 · Cited by 3
Poggi, A. I., Andreasen, M. W., Sahl, R. E., Hansen, M. T., Rømer, T., Frandsen, J., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., Ostrowski, S. R., et al. (2024) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14612 · Cited by 2
Mildly elevated liver lipid content is characterised by reduced insulin sensitivity
Tuomola, N., Rebelos, E., Latva‐Rasku, A., Bucci, M., Immonen, H., Saunavaara, V., Laine, S., Sjöros, T., Garthwaite, T., Raiko, J. R. H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101535 · Cited by 2
Fakhir, S. D., Arif, I. S., & Waheed, H. J. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e175259 · Cited by 2
Chiriacò, M., Tricò, D., Petrie, J. R., Gabriel, R., Gastaldelli, A., Nolan, J. J., Lalic, N. M., Mingrone, G., Mari, A., & Natali, A. (2025) · Diabetologia · doi:10.1007/s00125-025-06643-9 · Cited by 2
Pharmacologic approach to metabolic dysfunction and related diseases: focus on liver aspects
Piazzolla, V., Napolitano, A., & Mangia, A. (2025) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.152 · Cited by 2
Apaydın, T., Keklikkıran, Ç., Kani, H. T., Yilmaz, Y., & Yavuz, D. G. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02876-6 · Cited by 2
Reducing the risk of macrovascular complications of diabetes: focus on visceral fat
Sam, S., & Mazzone, T. (2011) · Diabetes Management · doi:10.2217/dmt.11.22 · Cited by 2
Metadata
- Authors
- Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- University of Pisa (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 133
- Issue
- 2
- Pages
- 496-506
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2136226749
- Cited by
- 629
- References
- 43
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 40 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 47 · 2016: 34 · 2015: 26 · 2014: 39 · 2013: 37 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hepatic insulin resistance, visceral fat, liver fat, abdominal fat accumulation, type 2 diabetes, obesity, hepatic glucose production, gluconeogenesis, hepatic steatosis, hyperinsulinemic-euglycemic clamp, subcutaneous adipose tissue, hepatic lipid accumulation, hepatic lipogenesis, hepatic lipolysis
- MeSH terms
- Adult, Aging, Blood Glucose, Diabetes Mellitus, Type 2, Female, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Glucose Clamp Technique, Body Mass Index, Abdominal Fat, Glycogenolysis, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review